Plasminogen: an enigmatic zymogen.

Abstract

Plasminogen is an abundant plasma protein that exists in various zymogenic forms. Plasmin, the proteolytically active form of plasminogen, is known for its essential role in fibrinolysis. To date, therapeutic targeting of the fibrinolytic system has been for 2 purposes: to promote plasmin generation for thromboembolic conditions or to stop plasmin to reduce bleeding. However, plasmin and plasminogen serve other important functions, some of which are unrelated to fibrin removal. Indeed, for >40 years, the antifibrinolytic agent tranexamic acid has been administered for its serendipitously discovered skin-whitening properties. Plasmin also plays an important role in the removal of misfolded/aggregated proteins and can trigger other enzymatic cascades, including complement. In addition, plasminogen, via binding to one of its dozen cell surface receptors, can modulate cell behavior and further influence immune and inflammatory processes. Plasminogen administration itself has been reported to improve thrombolysis and to accelerate wound repair. Although many of these more recent findings have been derived from in vitro or animal studies, the use of antifibrinolytic agents to reduce bleeding in humans has revealed additional clinically relevant consequences, particularly in relation to reducing infection risk that is independent of its hemostatic effects. The finding that many viruses harness the host plasminogen to aid infectivity has suggested that antifibrinolytic agents may have antiviral benefits. Here, we review the broadening role of the plasminogen-activating system in physiology and pathophysiology and how manipulation of this system may be harnessed for benefits unrelated to its conventional application in thrombosis and hemostasis.

• Authors: Charithani B Keragala, Robert L Medcalf
• Journal: Blood (Blood) Vol. 137 Issue 21 Pg. 2881-2889 (05 27 2021) ISSN: 1528-0020 [Electronic] United States
• PMID: 33735914 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
• Copyright: © 2021 by The American Society of Hematology.

Chemical References

• Antifibrinolytic Agents
• Fibrinolytic Agents
• PLGRKT protein, human
• Receptors, Cell Surface
• Tranexamic Acid
• Fibrin
• Plasminogen
• Fibrinolysin

Topics

• Animals
• Antifibrinolytic Agents (therapeutic use)
• Brain (enzymology)
• Conjunctivitis (physiopathology)
• Enzyme Activation
• Fibrin (metabolism)
• Fibrinolysin (physiology)
• Fibrinolysis (physiology)
• Fibrinolytic Agents (therapeutic use)
• Humans
• Immunity (physiology)
• Infections (physiopathology)
• Inflammation
• Mice
• Plasminogen (chemistry, deficiency, pharmacology, physiology, therapeutic use)
• Radiodermatitis (drug therapy)
• Receptors, Cell Surface (physiology)
• Skin Diseases, Genetic (physiopathology)
• Thrombosis (diagnosis, drug therapy)
• Tranexamic Acid (pharmacology, therapeutic use)
• Wound Healing (drug effects, physiology)
• Wounds and Injuries (drug therapy)